Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2025-12-24 @ 11:52 AM
NCT ID:
NCT00087061
Brief Title:
Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma
Official Title:
Oral ST1481 in Adults With Malignant Glioma: A Phase I-II Clinical Trial
Study:
NCT00087061
Protocol Section:
NCT00087061